0000940394-21-000422.txt : 20210219 0000940394-21-000422.hdr.sgml : 20210219 20210219083232 ACCESSION NUMBER: 0000940394-21-000422 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210219 DATE AS OF CHANGE: 20210219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eaton Vance Tax-Managed Buy-Write Income Fund CENTRAL INDEX KEY: 0001308927 IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-237555 FILM NUMBER: 21652111 BUSINESS ADDRESS: STREET 1: TWO INTERNATIONAL PLACE CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-482-8260 MAIL ADDRESS: STREET 1: TWO INTERNATIONAL PLACE CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: Eaton Vance Tax-Managed BuyWrite Income Fund DATE OF NAME CHANGE: 20041117 424B3 1 etbprosupp.htm EATON VANCE TAX-MANAGED BUY-WRITE INCOME FUND THRESHOLD SUPPLEMENT DTD 2-19-2021

Filed pursuant to Rule 424(b)(3)
File No. 333-237555

 

EATON VANCE TAX-MANAGED BUY-WRITE INCOME FUND
Supplement to Prospectus dated September 30, 2020 and Prospectus Supplement dated September 30, 2020

The following replaces any references, contained either in the Prospectus or the Prospectus Supplement, with respect to the Fund’s: (i) last reported sale price; (ii) net asset value (“NAV”) per Common Share; (iii) percentage premium to NAV per Common Share; (iv) number of Common Shares outstanding; and (v) net assets.

On February 18, 2021 the last reported sale price, NAV per Common Share and percentage premium to NAV per Common Share, were $14.90, $14.84 and 0.40%, respectively. As of February 18, 2021, we had 26,616,794 Common Shares outstanding and net assets of approximately $394,861,399.

The following replaces the last sentence in the first paragraph under “Use of Proceeds” in the Prospectus Supplement:

Assuming the sale of all of the Common Shares offered under this Prospectus Supplement and the accompanying Prospectus, at the last reported sale price of $14.90 per share for our Common Shares on the NYSE as of February 18, 2021, we estimate that the net proceeds of this offering will be approximately $21,875,349 after deducting the estimated sales load and the estimated offering expenses payable by the Fund.

 

February 19, 2021